Anti-vascular endothelial growth factor in neovascular age-related macular degeneration – a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-vascular endothelial growth factor in neovascular age-related macular degeneration – a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems
Authors
Keywords
-
Journal
BMC Ophthalmology
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-17
DOI
10.1186/s12886-020-01554-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real‐world 10‐year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age‐related macular degeneration
- (2019) Troels Brynskov et al. ACTA OPHTHALMOLOGICA
- Estimating Medicare and Patient Savings From the Use of Bevacizumab for the Treatment of Exudative Age-related Macular Degeneration
- (2018) Philip J. Rosenfeld et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Estimating Public and Patient Savings From Basic Research—A Study of Optical Coherence Tomography in Managing Antiangiogenic Therapy
- (2018) Matthew A. Windsor et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Age-related macular degeneration
- (2018) Paul Mitchell et al. LANCET
- OP70 Economic Impact Of Macular Edema Diseases, A Retrospective Study
- (2017) Gianluca Fabiano et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting
- (2017) Tsukasa Hanemoto et al. PLoS One
- Licence to save: a UK survey of anti-VEGF use for the eye in 2015
- (2016) A K Shalaby et al. EYE
- Vision-related quality of life: 12-month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration
- (2016) Meidong Zhu et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Treatment Patterns and Health Care Costs for Age-Related Macular Degeneration in Japan
- (2016) Atsuki Kume et al. OPHTHALMOLOGY
- UK Age-Related Macular Degeneration Electronic Medical Record System (AMD EMR) Users Group Report IV
- (2016) Robert L. Johnston et al. OPHTHALMOLOGY
- Anxiety levels and perceived pain intensity during intravitreal injections
- (2015) Ori Segal et al. ACTA OPHTHALMOLOGICA
- Long-term visual outcomes of intravitreal ranibizumab treatment for wet age-related macular degeneration and effect on blindness rates in south-east Scotland
- (2015) S Borooah et al. EYE
- Quality of Life in Patients Suffering from Active Exudative Age-Related Macular Degeneration: The EQUADE Study
- (2015) Emilie Matamoros et al. OPHTHALMOLOGICA
- Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
- (2014) Ursula Schmidt-Erfurth et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- The Impact of Anti–Vascular Endothelial Growth Factor Treatment on Quality of Life in Neovascular Age-Related Macular Degeneration
- (2014) Robert P. Finger et al. OPHTHALMOLOGY
- Estimated Cases of Blindness and Visual Impairment from Neovascular Age-Related Macular Degeneration Avoided in Australia by Ranibizumab Treatment
- (2014) Paul Mitchell et al. PLoS One
- The Effects of Technological Advances on Outcomes for Elderly Persons With Exudative Age-related Macular Degeneration
- (2014) Frank A. Sloan et al. JAMA Ophthalmology
- Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
- (2014) Wan Ling Wong et al. Lancet Global Health
- Incidence and baseline clinical characteristics of treated neovascular age-related macular degeneration in a well-defined region of the UK
- (2013) Tiarnan D L Keenan et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration
- (2013) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- COSTS OF NEWLY DIAGNOSED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AMONG MEDICARE BENEFICIARIES, 2004–2008
- (2013) Laura G. Qualls et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - A noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany
- (2012) Robert P. Finger et al. ACTA OPHTHALMOLOGICA
- Time Trends in the Incidence and Causes of Blindness in Israel
- (2012) Alon Skaat et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Incidence of Legal Blindness From Age-Related Macular Degeneration in Denmark: Year 2000 to 2010
- (2012) Sara Brandi Bloch et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Impact of Availability of Anti–Vascular Endothelial Growth Factor Therapy on Visual Impairment and Blindness Due to Neovascular Age-Related Macular Degeneration
- (2012) John P. Campbell et al. ARCHIVES OF OPHTHALMOLOGY
- Visual impairment certification secondary to ARMD in Leeds, 2005–2010: is the incidence falling?
- (2012) E Rostron et al. EYE
- Age-related macular degeneration
- (2012) Laurence S Lim et al. LANCET
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994–2007
- (2011) Shelley Day et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Estimated Cases of Legal Blindness and Visual Impairment Avoided Using Ranibizumab for Choroidal Neovascularization
- (2011) Neil M. Bressler et al. ARCHIVES OF OPHTHALMOLOGY
- Modelling the prevalence of age-related macular degeneration (2010-2020) in the UK: expected impact of anti-vascular endothelial growth factor (VEGF) therapy
- (2011) D. C. Minassian et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Global estimates of visual impairment: 2010
- (2011) Donatella Pascolini et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Depression Despite Anti–Vascular Endothelial Growth Factor Treatment of Age-Related Macular Degeneration
- (2010) Robin Casten ARCHIVES OF OPHTHALMOLOGY
- Rapid Expansion of Intravitreal Drug Injection Procedures, 2000 to 2008
- (2010) Robert J. Campbell ARCHIVES OF OPHTHALMOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Eye-Related Medicare Costs for Patients with Age-Related Macular Degeneration from 1995 to 1999
- (2007) Anne L. Coleman et al. OPHTHALMOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started